Hyaluronic acid-based nanocomposite hydrogels for ocular drug delivery applications

Journal of Biomedical Materials Research - Part A

Volumn 102, Issue 9, 2014, Pages 3056-3065

  Widjaja, Leonardus Kresna ^a   Bora, Meghali ^a   Chan, Paul Ng Poh Huat ^a   Lipik, Vitali ^a   Wong, Tina T L ^a   Venkatraman, Subbu S ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

hyaluronic acid; hydrogel; liposome; nanocomposite; ocular drug delivery

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADATION; BIOLOGICAL MATERIALS; CROSSLINKING; DRUG DELIVERY; HYALURONIC ACID; LIPOSOMES; NANOCOMPOSITES; ORGANIC ACIDS;

ADDITIONAL RESISTANCES; CHEMICALLY MODIFIED; COMPOSITE HYDROGELS; CONTROLLED DEGRADATION; INTRA OCULAR PRESSURE; NANOCOMPOSITE HYDROGELS; OCULAR DRUG DELIVERY; THERAPEUTIC APPLICATION;

HYDROGELS;

HYALURONIC ACID; LATANOPROST; LIPOSOME; NANOCOMPOSITE; ANTIHYPERTENSIVE AGENT; DELAYED RELEASE FORMULATION; HYDROGEL; PROSTAGLANDIN F;

ARTICLE; CONTROLLED STUDY; CROSS LINKING; ENZYMATIC DEGRADATION; EYE SWELLING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROGEL; HYDROLYSIS; LIPOSOMAL DELIVERY; MOLECULAR WEIGHT; NANOENCAPSULATION; PARTICLE SIZE; PROTON NUCLEAR MAGNETIC RESONANCE; ROOM TEMPERATURE; SHEAR STRESS; SUSTAINED DRUG RELEASE; SYNTHESIS; CHEMISTRY; DELAYED RELEASE FORMULATION; INTRAOCULAR DRUG ADMINISTRATION;

ADMINISTRATION, OPHTHALMIC; ANTIHYPERTENSIVE AGENTS; DELAYED-ACTION PREPARATIONS; HYALURONIC ACID; HYDROGELS; LIPOSOMES; NANOCOMPOSITES; PROSTAGLANDINS F, SYNTHETIC;

EID: 84904808113     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34976     Document Type: Article

References (46)

1. Laurent TC, Fraser JRE,. Hyaluronan. FASEB J. 1992; 6: 2397-2404.
2. Laurent TC, Laurent UB, Fraser JRE,. Functions of hyaluronan. Ann Rheum Dis 1995; 54: 429-432.
3. Laurent TC, Laurent UB, Fraser JRE,. The structure and function of hyaluronan: An overview. Immunol Cell Biol 1996; 74: A1-A7.
4. Chen WYJ, Abatangelo G,. Functions of hyaluronan in wound repair. Wound Rep Reg 1999; 7: 79-89.
5. Borzacchiello A, Ambrosio L, Netti P, Nicolais L,. Rheology of biological fluids and their substitutes. In:, Yaszemski MJ, Trantolo DJ, Lewandrowski KU, Hasirci V, Altobelli DE, Wise DL, editors. Tissue Engineering and Novel Delivery Systems. New York: Marcel Dekker; 2004. p 330-350.
6. Nickerson CS, Park J, Kornfield JA, Karageozian H,. Rheological properties of the vitreous and the role of hyaluronic acid. J Biomech 2008; 41: 1840-1846.
7. Le Goff MM, Bishop PN,. Adult vitreous structure and postnatal changes. Eye 2008; 22: 1214-1222.
8. Jin YJ, Ubonvan T, Kim DD,. Hyaluronic acid in drug delivery systems. J Pharm Invest 2010; 40: 33-43.
9. Liao YH, Jones SA, Forbes B, Martin GP, Brown MP,. Hyaluronan: Pharmaceutical characterization and drug delivery. Drug Deliv 2005; 12: 327-342.
10. Kogan G, Soltes L, Stern R, Gemeiner P,. Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications. Biotechnol Lett 2007; 29: 17-25.
11. Lapcik L, Stefaan D, Demeester J, Chabreccek P,. Hyaluronan: Preparation, structure, properties, and applications. Chem Rev 1998; 98: 2663-2684.
12. Balazs EA,. Viscoelastic Properties of Hyaluronan and Its Therapeutic Use. In:, Garg HG, Hales CA, editors. Chemistry and Biology of Hyaluronan. UK: Elsevier; 2004. p 415-455.
13. Falcone SJ, Palmeri D, Berg RA,. Biomedical applications of hyaluronic acid. In:, Marchessault RH, Ravenelle F, Zhu XX, editors. Polysaccharides for Drug Delivery and Pharmaceutical Applications. Washington, DC: American Chemical Society; 2006. p 155-174.
14. Segura T, Anderson BC, Chung PH, Webber RE, Shull KR, Shea LD,. Crosslinked hyaluronic acid hydrogels: a strategy to functionalize and pattern. Biomaterials 2005; 26: 359-371.
15. Zawko SA, Truong Q, Schmidt CE,. Drug-binding hydrogels of hyaluronic acid functionalized with β-cyclodextrin. J Biomed Mater Res A 2008; 87A: 1044-1052.
16. Schante CE, Zuber G, Herlin C, Vandamme CTF,. Chemical modifications of hyaluronic acid for the synthesis of derivatives for a broad range of biomedical applications. Carbohydr Polym 2011; 85: 469-489.
17. Burdick JA, Prestwich GD,. Hyaluronic acid hydrogels for biomedical applications. Adv Mater 2011; 23: H41-H56.
18. Xu X, Jha AK, Harrington DA, Farach-Carson MC, Jia X,. Hyaluronic acid-based hydrogels: from a natural polysaccharide to complex networks. Soft Matter 2012; 8: 3280-3294.
19. Mufamadi MS, Pillay V, Choonara YE, Du Toit LC, Modi G, Naidoo D, Ndesendo VMK,. A review on composite liposomal technologies for specialized drug delivery. J Drug Deliv 2011; 2011: 1-19.
20. Pjanovic R, Bosskovicc-Vragolovic N, Veljkovic-Giga J, Garic-Grulovic R, Pejanovic S, Bugarski B,. Diffusion of drugs from hydrogels and liposomes as drug carriers. J Chem Technol Biotechnol 2010; 85: 693-698.
21. Weiner AL, Carpenter-Green SS, Soehngen EC, Lenk RP, Popescu MC,. Liposome-collagen gel matrix:a novel sustained drug delivery system. J Pharm Sci 1985; 74: 922-925.
22. Mulik R, Kulkarni V, Murthy RSR,. Chitosan-based thermosensitive hydrogel containing liposomes for sustained delivery of cytarabine. Drug Dev Ind Pharm 2009; 35: 49-56.
23. Machluf M, Regev O, Peled Y, Kost J, Cohen S,. Characterization of microencapsulated liposome systems for the controlled delivery of liposome-associated macromolecules. J Control Release 1996; 43: 35-45.
24. Stenekes RJH, Loebis AE, Fernandes CM, Crommelin DJA, Hennink WE,. Degradable dextran microspheres for the controlled release of liposomes Pharm Res 2000; 17: 690-695.
25. Wang SS, Yang MC, Chung TW,. Liposomes/chitosan scaffold/human fibrin gel composite systems for delivering hydrophilic drugs-release behaviors of tirofiban in vitro. Drug Deliv 2008; 15: 149-157.
26. DiTizio V, Karlgard C, Lilge L, Khoury AE, Mittelman MW, DiCosmo F,. Localized drug delivery using crosslinked gelatin gels containing liposomes: Factors influencing liposome stability and drug release. J Biomed Mater Res 2000; 51: 96-106.
27. Hosny KM,. Ciprofloxacin as ocular liposomal hydrogel. AAPS Pharm Sci Tech 2010; 11: 241-246.
28. Budai L, Hajdu M, Budai M, Grof P, Beni S, Noszal B, Klebovich I, Antal I,. Gels and liposomes in optimized ocular drug delivery: Studies on ciprofloxacin formulations. Int JPharm 2007; 343: 34-40.
29. Mourtas S, Fotopoulou S, Duraj S, Sfika V, Tsakiroglou C, Antimisiaris SG,. Liposomal drugs dispersed in hydrogels: Effect of liposome, drug and gel properties on drug release kinetics. Colloids Surf B 2007; 55: 212-221.
30. Bochot A, Fattal E, Gulik A, Courraze G, Couvreur P,. Liposomes dispersed within a thermosensitive gel: a new dosage form for ocular delivery of oligonucleotides. Pharm Res 1998; 15: 1364-1369.
31. Nie S, Hsiao WLW, Pan W, Yang Z,. Thermoreversible Pluronic® F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release, cell cytotoxicity, and uptake studies. Int J Nanomed. 2011; 6: 151-166.
32. Liu Y, Li Z, Liang D,. Behaviors of liposomes in a thermo-responsive poly(N-isopropylacrylamide) hydrogel. Soft Matter 2012; 8: 4517-4523.
33. MacKinnon N, Guerin G, Liu B, Gradinaru CC, Macdonald PM,. Liposome-hydrogel bead complexes prepared via biotin-avidin conjugation. Langmuir 2009; 25: 9413-9423.
34. Davidson JM, Nanney LB, Broadley KN, Whitsett JS, Aquino AM, Beccaro M,. Hyaluronate derivatives and their application to wound healing: preliminary observations. Clin Mater 1991; 8: 171-177.
35. Narayanaswamy AK, Lee K, Zhen M, Chua J, Chai SM, Boey PY, Zheng C, Aung T, Venkatraman SS, Wong TT,. Randomized, controlled trial of a sustained delivery formulation of 5-fluorouracil for the treatment of failing blebs. Ophthalmology 2012; 119: 314-320.
36. Lajavardi L, Camelo S, Agnely F, Luo W, Goldenberg B, Naud MC, Behar-Cohen F, de Kozak Y, Bochot A,. New formulation of vasoactive intestinal peptide using liposomes in hyaluronic acid gel for uveitis. J Control Release 2009; 139: 22-30.
37. Sakai Y, Yasueda SI, Ohtori A,. Stability of latanoprost in an ophthalmic lipid emulsion using polyvinyl alcohol. Int JPharm 2005; 305: 176-179.
38. Natarajan JV, Ang M, Darwitan A, Chattopadhyay S, Wong TT, Venkatraman SS,. Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye. Int J Nanomed. 2012; 7: 123-131.
39. Luo Y, Kirker KR, Prestwich G,. Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery. J Control Release 2000; 69: 169-184.
40. Smeds KA, Pfister-Serres A, Miki D, Dastgheib K, Inoue M, Hatchell DL, Grinstaff MW,. Photocrosslinkable polysaccharides for in situ hydrogel formation. J Biomed Mater Res 2001; 54: 115-121.
41. Leach JB, Bivens KA, Patrick CW, Schmidt CE,. Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineering scaffolds biotechnol. Biotechnol Bioeng 2003; 82: 578-589.
42. Shah CB, Barnett SM,. Swelling behavior of hyaluronic acid gels. J Appl Polym Sci 1992; 45: 293-298.
43. Fraser JRE, Brown TJ, Laurent TC,. Catabolism of hyaluronan. In:, Laurent TC, Balazs EA, editors. The Chemistry, Biology and Medical Applications of Hyaluronan and its Derivatives. London: Portland Press; 1998. p 85-92.
44. Yeom J, Bhang SH, Kim BS, Seo MS, Hwang EJ, Cho IH, Park JK, Hahn SK,. Effect of cross-linking reagents for hyaluronic acid hydrogel dermal fillers on tissue augmentation and regeneration. Bioconjug Chem 2010; 21: 240-247.
45. Natarajan JV, Chattopadhyay S, Ang M, Darwitan A, Foo S, Zhen M, Koo M, Wong TT, Venkatraman SS,. Sustained release of an anti-glaucoma drug: demonstration of efficacy of a liposomal formulation in the rabbit eye. PLoS ONE 2011; 6: 1-10.
46. Stewart JCM,. Colorirnetric determination of phospholipids with ammonium ferrothiocyanat. Anal Biochem 1980; 104: 10-14.